These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 6090593)
1. Metabolism of ceramide trihexoside in cultured skin fibroblasts from Fabry's patients, carriers and normal controls. Kobayashi T; Shinnoh N; Kuroiwa Y J Neurol Sci; 1984 Aug; 65(2):169-77. PubMed ID: 6090593 [TBL] [Abstract][Full Text] [Related]
2. Fabry's disease with partially deficient hydrolysis of ceramide trihexoside. Kobayashi T; Kira J; Shinnoh N; Goto I; Kuroiwa Y J Neurol Sci; 1985 Feb; 67(2):179-85. PubMed ID: 2984338 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes. Fensom AH; Benson PF; Grant AR; Jacobs L J Inherit Metab Dis; 1980; 2(1):9-12. PubMed ID: 6273649 [TBL] [Abstract][Full Text] [Related]
4. Subclinical Fabry's disease occurring in the context of IgA nephropathy. Kawamura O; Sakuraba H; Itoh K; Suzuki Y; Doi M; Kuwabara H; Oshima S; Abe S; Warabi H; Yoshizawa N Clin Nephrol; 1997 Feb; 47(2):71-5. PubMed ID: 9049452 [TBL] [Abstract][Full Text] [Related]
5. [Biochemical and pathological studies on a carrier of Fabry's disease manifesting bouts of pain in the extremities]. Katayama M; Kobayashi T; Ohnishi A; Goto I; Kuroiwa Y Rinsho Shinkeigaku; 1984 Jun; 24(6):575-80. PubMed ID: 6094070 [No Abstract] [Full Text] [Related]
6. Avascular necrosis of the femoral head in a patient with Fabry's disease: identification of ceramide trihexoside in the bone by delayed-extraction matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. Horiuchi H; Saito N; Kobayashi S; Ota H; Taketomi T; Takaoka K Arthritis Rheum; 2002 Jul; 46(7):1922-5. PubMed ID: 12124877 [TBL] [Abstract][Full Text] [Related]
7. A female heterozygous patient with Fabry's disease with renal accumulation of trihexosylceramide detected with a monoclonal antibody. Fukushima M; Tsuchiyama Y; Nakato T; Yokoi T; Ikeda H; Yoshida S; Kusumoto T; Itoh K; Sakuraba H Am J Kidney Dis; 1995 Dec; 26(6):952-5. PubMed ID: 7503071 [TBL] [Abstract][Full Text] [Related]
8. A Fabry's disease heterozygote with a new mutation: biochemical, ultrastructural, and clinical investigations. Hasholt L; Sørensen SA; Wandall A; Andersen EB; Arlien-Søborg P J Med Genet; 1990 May; 27(5):303-6. PubMed ID: 2161929 [TBL] [Abstract][Full Text] [Related]
9. Detection of Fabry's disease heterozygotes by enzyme analysis in single fibroblasts after cell sorting. Jongkind JF; Verkerk A; Niermeijer MF Clin Genet; 1983 Apr; 23(4):261-6. PubMed ID: 6303650 [TBL] [Abstract][Full Text] [Related]
10. Total synthesis of ceramide trihexoside accumulating with Fabry's disease. Shapiro D; Acher AJ Chem Phys Lipids; 1978 Oct; 22(3):197-206. PubMed ID: 102432 [TBL] [Abstract][Full Text] [Related]
11. Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Elleder M; Bradová V; Smíd F; Budĕsínský M; Harzer K; Kustermann-Kuhn B; Ledvinová J; Bĕlohlávek ; Král V; Dorazilová V Virchows Arch A Pathol Anat Histopathol; 1990; 417(5):449-55. PubMed ID: 2173254 [TBL] [Abstract][Full Text] [Related]
12. Fabry's disease--a case report and review of literatures reported in Korea. Lee SY; Kim SJ; Lee JI; Kim ES; Lee CH; Kim JH; Jeong HJ; Ha SK Yonsei Med J; 1998 Feb; 39(1):67-72. PubMed ID: 9529988 [TBL] [Abstract][Full Text] [Related]
13. Restricted accumulation of globotriaosylceramide in the hearts of atypical cases of Fabry's disease. Ogawa K; Sugamata K; Funamoto N; Abe T; Sato T; Nagashima K; Ohkawa S Hum Pathol; 1990 Oct; 21(10):1067-73. PubMed ID: 2120125 [TBL] [Abstract][Full Text] [Related]
14. Properties of immobilized fig alpha-galactosidase and effect on ceramide-3 content of plasma from patients with Fabry's disease. Schram AW; Hamers MN; Oldenbroek-Haverkamp E; Strijland A; de Jonge A; van den Bergh FA; Tager JM Biochim Biophys Acta; 1978 Dec; 527(2):456-64. PubMed ID: 31916 [TBL] [Abstract][Full Text] [Related]
15. [Crystalline morphology of trihexosylceramide deposits characteristic of Fabry's disease (notably the rheumatic form)]. Laoussadi S; Dupoisot H; Constans A; Daury G; Delbarre F C R Seances Soc Biol Fil; 1981; 175(1):55-67. PubMed ID: 6261896 [TBL] [Abstract][Full Text] [Related]
16. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease. Mayes JS; Scheerer JB; Sifers RN; Donaldson ML Clin Chim Acta; 1981 May; 112(2):247-51. PubMed ID: 6263521 [TBL] [Abstract][Full Text] [Related]
18. Fabry's disease: clinical, pathologic and biochemical manifestations in two Chinese males. Sheu SS; Chan LP; Liao SC; Hsiao KJ; Shu KH; Lu YS; Cheng CH; Lian JD Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):368-72. PubMed ID: 7834562 [TBL] [Abstract][Full Text] [Related]
19. Genetics and Gene Therapy of Anderson-Fabry Disease. Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309 [TBL] [Abstract][Full Text] [Related]
20. The fate of internalized alpha-2-macroglobulin: alpha-galactosidase conjugate in fibroblasts from Fabry's hemizygote. Osada T; Kuroda Y; Ikai A Biochem Biophys Res Commun; 1987 Mar; 143(3):954-8. PubMed ID: 2436620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]